A new test from Stanford Medicine has been developed that can detect antibodies against COVID-19 in blood samples.
According to a press release on the test, the test looks for antibodies to the coronavirus in plasma, which can give more information about someone's immune response to an infection.
"Serological testing gives us a more comprehensive view of what's happening in an individual who is infected, or has been infected, with the virus," said Thomas Montine, MD, PhD professor and chair of pathology at the School of Medicine, in the press release.
People can expect the results from the test in two to three days. Currently, Stanford Health Care can test 500 samples per day, with the goal of scaling up quickly. Experts involved with the test are now determining who will receive it, with priority going to health care workers and others working in the hospital setting.
The researchers will be applying to the U.S. Food and Drug Administration (FDA) for an emergency use authorization (EUA) for the test.